AP
ACADIA Pharmaceuticals Inc
🇺🇸XNAS.ACADUnited StatesHealthcare
$27.32USDup +0.54 (+2.02%)OpenDelayed4:10 PM
Price$27.32+0.54 (+2.02%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0042251084
- CUSIP
- 004225108
Company
- Employees
- 796
- Headquarters
- San Diego, United States
- Website
- https://www.acadia.com
- CEO
- Ms. Catherine E. Owen Adams
Market
- Shares outstanding
- 172.3M
- Market cap
- $4.71B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $4.61B
- EPS LTM
- $2.20
- P/E LTM
- 11.57
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.14B+11.75%up year on year
- Net income
- $380.48M+71.27%up year on year
- Gross margin
- 91.13%-0.91%down year on year
- Free cash flow
- $174.39M-6.78%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.